• 1
    UNAIDS/WHO. Global report: UNAIDS report on the global AIDS Epidemic 2010. Joint United Nations Programme on HIV/AIDS 2010;UNAIDS/10.11E (JC1958E).
  • 2
    Quinn TC. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS 2008; 22 (Suppl 3): S712.
  • 3
    Boerma JT, Ghys PD, Walker N. Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard. Lancet 2003; 362: 19291931.
  • 4
    Instituto-Nacional-de-Saúde., Instituto-Nacional-de- Estatística., ICF-Macro. Inquérito Nacional de Prevalência, Riscos Comportamentais e Informaçao sobre o HIV e SIDA em Moçambique 2009. Calverton, MD, EUA:INS,INE e ICF Macro, 2010.
  • 5
    Glynn JR, Buve A, Carael M et al. Factors influencing the difference in HIV prevalence between antenatal clinic and general population in sub-Saharan Africa. AIDS 2001; 15: 17171725.
  • 6
    WHO, UNAIDS. Reconciling antenatal clinic-based surveillance and population-based survey estimates of HIV prevalence in Sub-Saharan Africa. WHO 2003.
  • 7
    Merson MH, O'Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet 2008; 372: 475488.
  • 8
    MISAU. Boletim de HIV/SIDA em Moçambique. Maputo, Mozambique: Boletim Departamento de Assistência Médica, 2005.
  • 9
    UNGASS. United Nations General Assambly Special Session on HIV and AIDS. Mozambique Progress Report 2008–2009. Maputo, Mozambique: UNAIDS, 2010.
  • 10
    Instituto-Nacional-de-Estatística. Tercer Recenseamento Geral da População e Habitação 2007. 2007.
  • 11
    Nhacolo AQ, Nhalungo DA, Sacoor CN, Aponte JJ, Thompson R, Alonso P. Levels and trends of demographic indices in southern rural Mozambique: evidence from demographic surveillance in Manhica district. BMC Public Health 2006; 6: 291.
  • 12
    Letang E, Almeida JM, Miro JM et al. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study. J Acquir Immune Defic Syndr 2010; 53: 589597.
  • 13
    Naniche D, Bardaji A, Lahuerta M et al. Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am J Trop Med Hyg 2009; 80: 870876.
  • 14
    Menendez C, Bardaji A, Sigauque B et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS ONE 2008; 3: e1934.
  • 15
    Naniche D, Lahuerta M, Bardaji A et al. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria. HIV Med 2008; 9: 757764.
  • 16
    Hallett TB, Zaba B, Todd J et al. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 2008; 5: e80.
  • 17
    Mutale W, Michelo C, Jurgensen M, Fylkesnes K. Home-based voluntary HIV counselling and testing found highly acceptable and to reduce inequalities. BMC Public Health 2010; 10: 347.
  • 18
    Stata-Corp-LP. STATA survey data reference manual. 2009.
  • 19
    Serna-Bolea C, Munoz J, Almeida JM et al. High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS 2010; 24: 603608.
  • 20
    Perez-Hoyos S, Naniche D, Macete E et al. Stabilization of HIV incidence in women of reproductive age in southern Mozambique. HIV Med 2011; 12: 500505.
  • 21
    Nyirenda M, Zaba B, Barnighausen T, Hosegood V, Newell ML. Adjusting HIV prevalence for survey non-response using mortality rates: an application of the method using surveillance data from Rural South Africa. PLoS ONE 2010; 5: e12370.
  • 22
    García-Calleja JM, Gouws E, Ghys PD. National population based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates. Sex Transm Infect 2006; 82 (Suppl III): iii64iii70.
  • 23
    Reniers G, Araya T, Berhane Y, Davey G, Sanders EJ. Implications of the HIV testing protocol for refusal bias in seroprevalence surveys. BMC Public Health 2009; 9: 163.
  • 24
    Barnighausen T, Bor J, Wandira-Kazibwe S, Canning D. Correcting HIV prevalence estimates for survey nonparticipation using Heckman-type selection models. Epidemiology 2011; 22: 2735.
  • 25
    Janssens W, de Beer I, Coutinho HM, van Rooy G, van der Gaag J, Rinke de Wit TF. Estimating HIV prevalence. A cautious note on household surveys in poor settings. BMJ 2010; 341: c6323.
  • 26
    Glynn JR, Carael M, Auvert B et al. Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia. AIDS 2001; 15 (Suppl 4): S51S60.
  • 27
    Pettifor AE, Rees HV, Kleinschmidt I et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005; 19: 15251534.
  • 28
    Wira CR, Fahey JV. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22: 19091917.
  • 29
    Meier A, Chang JJ, Chan ES et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009; 15: 955959.
  • 30
    Chersich MF, Rees HV. Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS 2008; 22 (Suppl 4): S27S40.
  • 31
    Connolly C, Shisana O, Colvin M, Stoker D. Epidemiology of HIV in South Africa – results of a national, community-based survey. S Afr Med J 2004; 94: 776781.
  • 32
    Menendez C, Castellsague X, Renom M et al. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infect Dis Obstet Gynecol 2010; doi:10.1155/2010/609315.
  • 33
    Hoshaw-Woodard S, Biologicals WDV. Description and comparison of the methods of cluster sampling and lot quality assurance sampling to assess immunization coverage. WHO 2001;WHO/V&B/0.26.
  • 34
    Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 1991; 44: 98106.
  • 35
    Fylkesnes K, Ndhlovu Z, Kasumba K, Mubanga Musonda R, Sichone M. Studying dynamics of the HIV epidemic: population-based data compared with sentinel surveillance in Zambia. AIDS 1998; 12: 12271234.
  • 36
    Gregson S, Terceira N, Kakowa M et al. Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS 2002; 16: 643652.
  • 37
    Zaba B, Terceira N, Mason P, Gregson S. The contribution of HIV to fertility decline in rural Zimbabwe, 1985–2000. Popul Stud (Camb) 2003; 57: 149164.
  • 38
    Zaba B, Gregson S. Measuring the impact of HIV on fertility in Africa. AIDS 1998; 12 (Suppl 1): S41S50.
  • 39
    Wand H, Ramjee G. Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa. J Int AIDS Soc 2010; 13: 41.
  • 40
    Sume GE, Etogo D, Kabore S, Gnigninanjouena O, Epome SS, Metchendje JN. Seroprevalence of human immunodeficiency virus infection among tuberculosis patients in the Nylon district hospital tuberculosis treatment centre. East Afr Med J 2008; 85: 529536.
  • 41
    Rice BD, Batzing-Feigenbaum J, Hosegood V et al. Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 2007; 7: 160.
  • 42
    Gregson S, Gonese E, Hallett TB et al. HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol 2011; 39: 13111323.
  • 43
    Barnighausen T, Tanser F, Hallett T, Newell ML. Short communication: prioritizing communities for HIV prevention in sub-Saharan Africa. AIDS Res Hum Retroviruses 2010; 26: 401405.
  • 44
    Wong KF, Tsai WY, Kuhn L. Estimating HIV hazard rates from cross-sectional HIV prevalence data. Stat Med 2006; 25: 24412449.